within Pharmacolibrary.Drugs.ATC.N;

model N01AG01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 5e-05,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,   // mg â†’ kg
    adminCount     = 1,
    Vd             = 0.0007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0005,
    k12             = 1,
    k21             = 1
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N01AG01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Narcobarbital is a barbiturate derivative formerly used primarily as an anesthetic and sedative in veterinary medicine. It is not approved for human use and is largely discontinued or obsolete in modern clinical practice.</p><h4>Pharmacokinetics</h4><p>No direct published pharmacokinetic data for narcobarbital in humans or animals are available. The following values are estimated based on known barbiturate pharmacokinetic properties (e.g., pentobarbital, thiopental) and structural similarity.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N01AG01;
